Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacy and Therapeutics|February 1, 1990
Phenytoin dosage individualization--five methods compared in the elderlyS A Hudson, D L Farquhar, D Thompson, et al.
Pharmacy World & Science : PWS|November 28, 2001
Identification of the pharmaceutical care issues of rheumatoid arthritis patients in secondary careR O'Hare, A Muir, S Chapman, et al.
Pharmacy World & Science : PWS|November 28, 2001
Evaluation of the implementation of a local treatment guideline in secondary prevention post-myocardial infarctionF Reid, B Fossland, A D Flapa, et al.
British Journal of Clinical Pharmacology|May 1, 1986
A comparison of the pharmacokinetics of propranolol in obese and normal volunteersS L Bowman, S A Hudson, G Simpson, et al.
The Journal of Allergy and Clinical Immunology|November 18, 2000
Expression and function of P-selectin glycoprotein ligand 1 (CD162) on human basophilsM L Taylor, M E Brummet, S A Hudson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
CCR3-active chemokines promote rapid detachment of eosinophils from VCAM-1 in vitroH Tachimoto, M M Burdick, S A Hudson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitroK L Davenpeck, M E Brummet, S A Hudson, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 1, 1996
Comparative study of the determination of bupivacaine in human plasma by gas chromatography-mass spectrometry and high-performance liquid chromatographyA Tahraoui, D G Watson, G G Skellern, et al.
Scientific Reports|March 5, 2025
Prevalence of dementia risk factors in the Oxford Brain Health ClinicJ Blane, G Gillis, L Griffanti, et al.
Pageof 3